Ti-Tre Tablets 20mcg (liothyronine) - Important Safety Information from Irish Medicines Board

Notice type: 3rd Party Publications

Date: 19/06/2012

 

Problem Or Issue:
Important Safety Information communication from the Irish Medicines Board in relation to a potential quality issue with the exempt medicinal product Ti-Tre 20mcg tablets. Update: As of August 2012, replacement, unaffected Ti-Tre stock is available from wholesalers.

Important Safety Information - Ti-Tre 20mcg


« Back